THE COMPLICATED CLINICAL COURSE IN A CASE OF ATYPICAL LIPODYSTROPHY AFTER DEVELOPMENT OF NEUTRALIZING ANTIBODY TO METRELEPTIN: TREATMENT WITH SETMELANOTIDE

The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide

A patient with atypical partial lipodystrophy who had a transient initial response to metreleptin experienced acute worsening of her metabolic state when neutralizing antibodies against metreleptin appeared.Because her metabolic status continued to deteriorate, a therapeutic trial with melanocortin-4 receptor agonist setmelanotide, that is believed

read more